July 2018
Volume 59, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2018
Antioxidant Protection of a Model Tear-Film Component in Soft Contact Lenses
Author Affiliations & Notes
  • Charles W Scales
    Research & Development, Johnson & Johnson Vision, Jacksonville, Florida, United States
  • Shivkumar Mahadevan
    Research & Development, Johnson & Johnson Vision, Jacksonville, Florida, United States
  • Leilani Sonoda
    Research & Development, Johnson & Johnson Vision, Jacksonville, Florida, United States
  • Mark Lada
    Research & Development, Johnson & Johnson Vision, Jacksonville, Florida, United States
  • Patricia Martin
    Research & Development, Johnson & Johnson Vision, Jacksonville, Florida, United States
  • Donald Riederer
    Research & Development, Johnson & Johnson Vision, Jacksonville, Florida, United States
  • Zohra Fadli
    Research & Development, Johnson & Johnson Vision, Jacksonville, Florida, United States
  • Footnotes
    Commercial Relationships   Charles Scales, Johnson & Johnson Vision Care (F); Shivkumar Mahadevan, Johnson & Johnson Vision Care (F); Leilani Sonoda, Johnson & Johnson Vision Care (F); Mark Lada, Johnson & Johnson Vision Care (F); Patricia Martin, Johnson & Johnson Vision Care (F); Donald Riederer, Johnson & Johnson Vision Care (F); Zohra Fadli, Johnson & Johnson Vision Care (F)
  • Footnotes
    Support  Johnson & Johnson Vision Care
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 1769. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Charles W Scales, Shivkumar Mahadevan, Leilani Sonoda, Mark Lada, Patricia Martin, Donald Riederer, Zohra Fadli; Antioxidant Protection of a Model Tear-Film Component in Soft Contact Lenses. Invest. Ophthalmol. Vis. Sci. 2018;59(9):1769.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : The tear-film contains naturally occurring anti-oxidants essential to preserving beneficial components, i.e. lipids and proteins, and maintaining ocular homeostasis. Soft contact lens (CL) materials interact with the tear-film (TF) in different ways, with some taking up large amounts of protein/lipids with minimal to no negative clinical impact. This uptake may be beneficial, as long as the components do not oxidize and degrade during wear. Herein, the benefits of using an antioxidant, i.e. a UV-blocking, phenolic benzotriazole known as Norbloc (NB), in a CL to curtail degradation of a TF component, namely, cholesterol (CH), is demonstrated.

Methods : Two experimental silicone hydrogel lens formulations were prepared with and without NB, i.e. (L1) and (L2), respectively. Both were subjected to incubation with CH followed by exposure to oxidative conditions with prescribed doses of hydrogen peroxide (H2O2) (0, 3, and 10 % in PBS), UV exposure (24 hours, at 3 mW/cm2), and combinations thereof. The extent of lipid oxidation within L1 and L2 after each exposure condition was determined via high performance liquid chromatography with mass spectrometry (HPLC-MS) analysis of lens extracts. The appearance of two oxidative degradants of CH, namely, 5α,6α-Epoxycholestan-3β-ol (αCHEI) and 5β,6β-Epoxycholestan-3β-ol (βCHEI), was used to assess the extent of lipid oxidation.

Results : Generally, higher levels of CH epoxides (i.e. α- and β-CHEI) were observed with L2 lenses after exposure to H2O2 and UV compared to L1 lenses. Following exposure to 10 % H2O2 and UV for 24 hrs. at 3 mW/cm2, L2 lenses showed statistically higher amounts of CH degradation to αCHEI (10.1 % ± 1.57) compared to L1 lenses (7.3 % ± 1.94, p=0.020). Under identical conditions, the L2 lenses also showed a statistically higher amount of CH degradation to βCHEI (7.3 % ± 1.15) compared to L1 lenses (3.8 % ± 0.99 p=0.001).

Conclusions : The use of an antioxidant in CLs imparts a protective effect onto adsorbed/absorbed TF components such as CH, i.e. lipid degradation is lower in a CL that contains NB, compared to one that does not. These data support the hypothesis that use of an antioxidant in a CL may help maintain TF components in their native state in vivo, which may positively impact clinical performance.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×